1. Home
  2. WING vs GPCR Comparison

WING vs GPCR Comparison

Compare WING & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wingstop Inc.

WING

Wingstop Inc.

HOLD

Current Price

$246.33

Market Cap

6.7B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$64.32

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WING
GPCR
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.3B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
WING
GPCR
Price
$246.33
$64.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
26
11
Target Price
$339.88
$104.64
AVG Volume (30 Days)
1.1M
796.4K
Earning Date
05-22-2026
05-29-2026
Dividend Yield
0.50%
N/A
EPS Growth
67.84
N/A
EPS
6.21
N/A
Revenue
$696,853,000.00
N/A
Revenue This Year
$19.88
N/A
Revenue Next Year
$16.90
N/A
P/E Ratio
$38.31
N/A
Revenue Growth
11.35
N/A
52 Week Low
$204.09
$13.24
52 Week High
$388.14
$94.90

Technical Indicators

Market Signals
Indicator
WING
GPCR
Relative Strength Index (RSI) 46.34 34.74
Support Level $227.67 $60.42
Resistance Level $276.53 $72.00
Average True Range (ATR) 18.07 3.49
MACD -0.76 -1.15
Stochastic Oscillator 33.71 20.98

Price Performance

Historical Comparison
WING
GPCR

About WING Wingstop Inc.

Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, expanding to 2,932 global stores at the end of the third quarter of 2025. With a 98% franchised model, Wingstop generates the lion's share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: